IP Library › Granted Patent US 12,247,914
Granted Patent B2
US 12,247,914 · App. 18/173,897 · Granted Mar 11, 2025

Virus sensing in exhaled breath by infrared spectroscopy

Inventor: Kurt J. Linden (Wayland, MA)
Assignee: VOX BIOMEDICAL LLC
G01N21/3504G01N21/39G01N33/497G01N2021/396G01N33/4975
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,247,914
App. No.
18/173,897
Granted
Mar 11, 2025
Kind
B2
Abstract

Techniques for detecting cannabinoid, opioid, and virus aerosols in an exhaled breath are provided. An example method for analyzing exhaled breath includes receiving an aerosol breath sample, concentrating the aerosol breath sample onto an infrared-transparent coupon with an electrostatic precipitator, disposing the infrared-transparent coupon in an optical path of a spectroscopy system, detecting one or more infrared spectral features of the concentrated aerosol breath sample with the spectroscopy system, and analyzing the aerosol breath sample based on the one or more infrared spectral features.

Claims (36)

1. A method of analyzing exhaled breath, comprising:

receiving an aerosol breath sample;

concentrating the aerosol breath sample onto an infrared-transparent coupon with an electrostatic precipitator;

disposing the infrared-transparent coupon in an optical path of a spectroscopy system;

detecting one or more infrared spectral features of the concentrated aerosol breath sample with the spectroscopy system; and

analyzing the aerosol breath sample based on the one or more infrared spectral features.

2. The method of claim 1 wherein the infrared-transparent coupon comprises a doped silicon substrate.

3. The method of claim 2 wherein the infrared-transparent coupon further comprises a patterned oxide disposed on the doped silicon substrate.

4. The method of claim 3 wherein the patterned oxide disposed on the doped silicon substrate includes at least one opening of 1 millimeter or less.

5. The method of claim 1 wherein the spectroscopy system includes an optical frequency comb laser with a separation of laser modes of 0.33 cm −1 or less and is configured to transmit light through the infrared-transparent coupon.

6. The method of claim 1 wherein the spectroscopy system includes a tunable quantum cascade laser.

7. The method of claim 1 wherein the spectroscopy system includes a tunable laser such as a diode laser, a solid-state laser, a gas laser or other type of laser whose output optical frequency can be electronically or mechanically controlled.

8. The method of claim 1 wherein analyzing the aerosol breath sample includes detecting a virus based on the one or more infrared spectral features being between 1724 cm −1 and 1492 cm −1 .

9. The method of claim 1 wherein analyzing the aerosol breath sample includes detecting tetrahydrocannabinol (THC) based on the one or more infrared spectral features being a spectral absorption line at approximately 1036.94 cm-1.

10. The method of claim 1 wherein analyzing the aerosol breath sample includes detecting oxycodone based on the one or more infrared spectral features being spectral absorption lines approximately between 700-1500 cm-1.

11. The method of claim 1 wherein analyzing the aerosol breath sample includes detecting fentanyl based on the one or more infrared spectral features being spectral absorption lines approximately between 600-1500 cm-1.

12. The method of claim 1 wherein analyzing the aerosol breath sample includes detecting morphine based on the one or more infrared spectral features being spectral absorption lines approximately between 600-1130 cm-1.

13. A method of analyzing exhaled breath, comprising:

capturing a breath input with a collection coupon in an electrostatic precipitator;

disposing the collection coupon in an optical path in a spectroscopy system;

detecting one or more infrared spectral features of the breath input with the spectroscopy system; and

analyzing the breath input based on the one or more infrared spectral features.

14. The method of claim 13 wherein the collection coupon comprises a doped silicon substrate.

15. The method of claim 14 wherein the collection coupon further comprises a patterned oxide disposed on the doped silicon substrate.

16. The method of claim 15 wherein the patterned oxide disposed on the doped silicon substrate includes at least one opening of 1 millimeter or less.

17. The method of claim 13 wherein the spectroscopy system includes an optical frequency comb laser with a separation of laser modes of 0.33 cm −1 or less and is configured to transmit light through the collection coupon.

18. The method of claim 13 wherein the spectroscopy system includes a tunable laser such as a diode laser, a tunable quantum cascade laser, a solid-state laser, a gas laser or other type of laser whose output optical frequency can be electronically or mechanically controlled.

19. An apparatus for analyzing exhaled breath, comprising:

a memory;

an infrared laser source;

at least one infrared detector such as a photon detector, thermal detector, photoacoustic detector or other detector of infrared light;

an electrostatic precipitator configured to concentrate a breath aerosol sample on a collection coupon, wherein the collection coupon is configured to be disposed between the infrared laser source and the at least one infrared detector;

at least one processor communicatively coupled to the memory, the infrared laser source, the at least one infrared detector, and configured to:

detect one or more infrared spectral features of the concentrated breath aerosol sample on the collection coupon; and

analyze the exhaled breath based on the one or more infrared spectral features.

20. The apparatus of claim 19 wherein the collection coupon comprises a doped silicon substrate with a patterned oxide including an opening of 1 millimeter or less.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2023
From: LINDEN, KURT J.
To: VOX BIOMEDICAL LLC
Reel/Frame 062794/0096 →
Continuity (4)
Continuation In Part 17190777 · Mar 3, 2021
Continuation In Part 16043246 · Jul 24, 2018
Provisional Application 62540115 · Aug 2, 2017
Related Publication 20230204501A1 · Jun 29, 2023
References Cited (50)
US 6555821B1 · Himberg et al. · 2003 [cited by applicant]
US 9709582B1 · Gordon · 2017 [cited by examiner]
US 20050150385A1 · Huang et al. · 2005 [cited by applicant]
US 20060165606A1 · Tarara et al. · 2006 [cited by applicant]
US 20100159575A1 · Chen · 2010 [cited by applicant]
US 20110170098A1 · Normand · 2011 [cited by applicant]
US 20120133931A1 · Fermann et al. · 2012 [cited by applicant]
US 20120212735A1 · Palmskog et al. · 2012 [cited by applicant]
US 20130006068A1 · Gemer et al. · 2013 [cited by applicant]
US 20140288454A1 · Paz et al. · 2014 [cited by applicant]
US 20150233762A1 · Goldring et al. · 2015 [cited by applicant]
US 20150298069A1 · Bae et al. · 2015 [cited by applicant]
US 20160061807A1 · Ravishankar et al. · 2016 [cited by applicant]
US 20160139055A1 · Pierce, III et al. · 2016 [cited by applicant]
US 20160153835A1 · Lee et al. · 2016 [cited by applicant]
US 20160299061A1 · Goldring et al. · 2016 [cited by applicant]
EP 0897708A2 · 1999 [cited by applicant]
JP 2004537038A · 2004 [cited by applicant]
Davis et al., “Analysis of Volatile and Non-Volatile Biomarkers in Human Breath Using Differential Mobility Spectrometry (DMS)”, IEEE Sensors Journal, vol. 10, No. 1, pp. 114-122. (Year: 2010). [cited by examiner]
CDCNCHS, “Underlying Cause of Death,” wonder.cdc.gov, 1999-2016 Results Form pp. 1-4. [cited by applicant]
Florence et al., “The Economic Burden of Prescription Opioid Overdose, Abuse and Dependence in the United States,” 2013, HHS Public Access, Med Care, PMC 2018, pp. 1-14. [cited by applicant]
Cicero et al., “The Changing Face of Heroin Use in the United States,” JAMA Psychiatry, Jul. 2014, vol. 71, No. 7, pp. 821-826. [cited by applicant]
The Recovery Village, “How Do I Know if Someone Is on Opiates?”, www.therecoveryvillage.com/opiate-addiction, pp. 1-7, Jul. 19, 2018. [cited by applicant]
Nida, “Medications to Treat Opioid Use Disorder,” Jun. 2018, www.drugabuse.gov, pp. 1-47. [cited by applicant]
Law et al., “Analyticala Methodology and Assessment of Potential Second-Hand Exposure to Fentanyl in the Hospital Setting,” Journal of Addictive Diseases, vol. 29, 2010, Issue 1, Abstract. [cited by applicant]
Beck et al., “Determination of Amphetamine and Methylphenidate in Exhaled Breath of Patients Undergoing ADHD Treatment,” The Drug Monit, 2014, pp. 1-7. [cited by applicant]
Milone, “Laboratory Testing for Prescription Opioids,” J. Med. Toxicol., 2012, vol. 8, pp. 408-416. [cited by applicant]
Beck et al., “Study of the Sampling of Methadone From Exhaled Breath,” PMID: 21619719, Indexed for Medline, J. Anal. Toxicol, Jun. 2011; 35(5) 257-63. [cited by applicant]
Xi et al., “Detecting Lung Diseases from Exhaled Aerosols: Non-Invasive Lung Diagnosis Using Fractal Analysis and SVM Classification,” PLOS One, 2015, pp. 1-19. [cited by applicant]
Yan et al., “Infectious Virus in Exhaled Breath of Symptomatic Seasonal Influenza Cases From a College Community,” www.pnas.org/cgi/doi pp. 1-10, PNAS Early Edition, Dec. 15, 2017. [cited by applicant]
Linden, “Driver Breath Measurement of Marijuana Intoxication by Infrared Spectroscopy,” Submitted to U.S. Dept. of Transportation SBIR Program, 2017, pp. 1-33. [cited by applicant]
Bruker, Advertisement for Company Products, Applications, Service, News Events Jul. 19, 2018. [cited by applicant]
Worle et al., “Breath Analysis With Broadly Tunable Quantum Cascade Lasers,” Analytical Chemistry, 2013, vol. 85, pp. 2697-2702. [cited by applicant]
NIST Chemistry WebBook, NIST Standard Reference Database No. 69, Jun. 21, 2017. [cited by applicant]
Matteo et al., “Analysis of Functional Groups in Atmospheric Aerosols by Infrared Spectroscopy,” Infoscience, EPFL Scientific Publications, Oct. 14, 2016. [cited by applicant]
Ye et al., “Sparse Methods for Biomedical Data,” NIH Public Access, SIGKDD Explor: Author Manuscript, 2013, pp. 1-24. [cited by applicant]
Kallet, “The Role of Inhaled Opioids and Furosemide for the Treatment of Dyspnea,” Respiratory Care, Jul. 2007, vol. 52, No. 7, pp. 900-910. [cited by applicant]
Foral et al., “Nebulized Opioids Use in COPD,” Abstract, PubMed.gov, Chest. Feb. 2004; 125(2): 691-4. [cited by applicant]
Sigma Product Information, 9-Tetrahydrocannabinol, 2004, available online at www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/sigma-aldrich/datasheet/1/t4764-091k8801dat.pdf, 2 pages (Year: 2004). [cited by applicant]
Sigma-Aldrich Product information, Oxycodone hydrochloride solution, 2015, available online at www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/sigma-aldrich/datasheet/1/02628-slbn2071vdat.pdf, 2 pages (Year: 2015). [cited by applicant]
Ohta et al., “Studies on Fentanyl and Related Compounds IV, chromatographic and spectrometic discrimination of derivatives,” Aug. 1999, Journal of Analytical Toxicology, vol. 23, pp. 280-295 (Year: 1999). [cited by applicant]
Bartels et al., “10-GHz self-referenced optical frequency comb,” Oct. 30, 2009, Science, vol. 326, two pages (Year: 2009). [cited by applicant]
Fabian et al., “Influenza Virus in Human Exhaled Breath: An Observational Study,” PLoS ONE, www.plosone.org, Jul. 2008, vol. 3, Issue 7, 6 pages. [cited by applicant]
Khan et al., “Spectroscopy as a tool for detection and monitoring of Coronavirus (COVID-19),” Expert Review of Molecular Diagnostics, https://doi.org/10.1080/14737159.2020.1766968, May 5, 2020, 3 pages. [cited by applicant]
Lausted et al., “Maximum static inspiratory and expiratory pressures with different lung volumes,” BioMedical Engineering OnLine 2006, 5:29, doi: 10.1186/1475-925X-5-29; May 5, 2006, 6 pages. [cited by applicant]
Fortier et al., “20 years of developments in optical frequency comb technology and applications,” Communications Physics, (2019) 2:153, https://doi.org/10.1038/s42005-019-0249-y, 16 pages. [cited by applicant]
Thorpe et al., “Cavity-enhanced optical frequency comb spectroscopy: application to human breath analysis,”. [cited by applicant]
Laila Ladhani et al., “Sampling and detection of airborne influenza virus towards point-of-care applications,” Plos One, https://doi.org/10.1371/journal.pone.0174314, Mar. 28, 2017, 15 pages. [cited by applicant]
Gaspard Pardon et al., “Aerosol sampling using an electrostatic precipitator integrated with a microfluidic interface,” Sensors and Actuators B: Chemical, vol. 212, Jun. 2015, https://doi.org/10.1016/j.snb.2015.02.008, … [cited by applicant]
Laila Ladhani et al., “Electrostatic Sampling of Patient Breath for Pathogen Detection: A Pilot Study,” Frontiers in Mechanical Engineering, vol. 6, Article 40, Jun. 2020, 7 pages. [cited by applicant]